APO Research
Talk to an analyst

APO RESEARCH · REPORT

Liposomes

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Liposomes Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025192 pages

Choose your research edition.

Industry ResearchLiposomes Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Liposomes Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Liposomes Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Liposomes Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Liposomes Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Liposomes market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Liposomes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Liposomes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Liposomes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Liposomes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Liposomes include CSPC, Fudan-Zhangjiang, Gilead Sciences, Kingond Pharm, Luye Pharma, Pacira, Sigma-Tau Group, Spectrum Pharmaceuticals and Teva Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Liposomes market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Liposomes and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Liposomes sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Liposomes market size, projected growth trends, production technologies, key applications, and end-use industries.

Liposomes Segment by Company

CSPC

Fudan-Zhangjiang

Gilead Sciences

Kingond Pharm

Luye Pharma

Pacira

Sigma-Tau Group

Spectrum Pharmaceuticals

Teva Pharmaceutical

Novartis

Johnson & Johnson

Shanghai New Asia

Sun Pharmaceutical

Liposomes Segment by Type

Liposomal Doxorubicin

Liposomal Amphoteracin B

Liposomal Paclitaxel

Others

Liposomes Segment by Application

Fungal Infection Therapy

Cancer & Tumor Therapy

Others

Liposomes Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liposomes market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Liposomes and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liposomes.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Liposomes market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Liposomes manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Liposomes in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Liposomes in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Liposomes Industry Trends Table 2. Liposomes Industry Drivers Table 3. Liposomes Industry Opportunities and Challenges Table 4. Liposomes Industry Restraints Table 5. Global Liposomes Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Liposomes Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Liposomes Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Liposomes Sales Market Share by Manufacturers Table 9. Global Liposomes Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Liposomes Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Liposomes Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Liposomes Manufacturers, Product Type & Application Table 13. Global Liposomes Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Liposomes by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Liposomal Doxorubicin Table 17. Major Manufacturers of Liposomal Amphoteracin B Table 18. Major Manufacturers of Liposomal Paclitaxel Table 19. Major Manufacturers of Others Table 20. Global Liposomes Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 21. Global Liposomes Sales by Type (2021-2026) & (W Units) Table 22. Global Liposomes Sales by Type (2027-2032) & (W Units) Table 23. Global Liposomes Sales Market Share by Type (2021-2026) Table 24. Global Liposomes Sales Market Share by Type (2027-2032) Table 25. Global Liposomes Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 26. Global Liposomes Revenue by Type (2021-2026) & (W Units) Table 27. Global Liposomes Revenue by Type (2027-2032) & (W Units) Table 28. Global Liposomes Revenue Market Share by Type (2021-2026) Table 29. Global Liposomes Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Fungal Infection Therapy Table 31. Major Manufacturers of Cancer & Tumor Therapy Table 32. Major Manufacturers of Others Table 33. Global Liposomes Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 34. Global Liposomes Sales by Application (2021-2026) & (W Units) Table 35. Global Liposomes Sales by Application (2027-2032) & (W Units) Table 36. Global Liposomes Sales Market Share by Application (2021-2026) Table 37. Global Liposomes Sales Market Share by Application (2027-2032) Table 38. Global Liposomes Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 39. Global Liposomes Revenue by Application (2021-2026) & (W Units) Table 40. Global Liposomes Revenue by Application (2027-2032) & (W Units) Table 41. Global Liposomes Revenue Market Share by Application (2021-2026) Table 42. Global Liposomes Revenue Market Share by Application (2027-2032) Table 43. Global Liposomes Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 44. Global Liposomes Sales by Region (2021-2026) & (W Units) Table 45. Global Liposomes Sales Market Share by Region (2021-2026) Table 46. Global Liposomes Sales Forecasted by Region (2027-2032) & (W Units) Table 47. Global Liposomes Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Liposomes Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 49. North America Liposomes Sales by Country (2021-2026) & (W Units) Table 50. North America Liposomes Sales by Country (2027-2032) & (W Units) Table 51. Europe Liposomes Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 52. Europe Liposomes Sales by Country (2021-2026) & (W Units) Table 53. Europe Liposomes Sales by Country (2027-2032) & (W Units) Table 54. Asia Pacific Liposomes Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 55. Asia Pacific Liposomes Sales by Country (2021-2026) & (W Units) Table 56. Asia Pacific Liposomes Sales by Country (2027-2032) & (W Units) Table 57. South America, Middle East and Africa Liposomes Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 58. South America, Middle East and Africa Liposomes Sales by Country (2021-2026) & (W Units) Table 59. South America, Middle East and Africa Liposomes Sales by Country (2027-2032) & (W Units) Table 60. Global Liposomes Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Liposomes Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Liposomes Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Liposomes Revenue Market Share by Region (2021-2026) Table 64. Global Liposomes Revenue Market Share by Region (2027-2032) Table 65. CSPC Company Information Table 66. CSPC Business Overview Table 67. CSPC Liposomes Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. CSPC Liposomes Product Portfolio Table 69. CSPC Recent Development Table 70. Fudan-Zhangjiang Company Information Table 71. Fudan-Zhangjiang Business Overview Table 72. Fudan-Zhangjiang Liposomes Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Fudan-Zhangjiang Liposomes Product Portfolio Table 74. Fudan-Zhangjiang Recent Development Table 75. Gilead Sciences Company Information Table 76. Gilead Sciences Business Overview Table 77. Gilead Sciences Liposomes Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Gilead Sciences Liposomes Product Portfolio Table 79. Gilead Sciences Recent Development Table 80. Kingond Pharm Company Information Table 81. Kingond Pharm Business Overview Table 82. Kingond Pharm Liposomes Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Kingond Pharm Liposomes Product Portfolio Table 84. Kingond Pharm Recent Development Table 85. Luye Pharma Company Information Table 86. Luye Pharma Business Overview Table 87. Luye Pharma Liposomes Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Luye Pharma Liposomes Product Portfolio Table 89. Luye Pharma Recent Development Table 90. Pacira Company Information Table 91. Pacira Business Overview Table 92. Pacira Liposomes Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Pacira Liposomes Product Portfolio Table 94. Pacira Recent Development Table 95. Sigma-Tau Group Company Information Table 96. Sigma-Tau Group Business Overview Table 97. Sigma-Tau Group Liposomes Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Sigma-Tau Group Liposomes Product Portfolio Table 99. Sigma-Tau Group Recent Development Table 100. Spectrum Pharmaceuticals Company Information Table 101. Spectrum Pharmaceuticals Business Overview Table 102. Spectrum Pharmaceuticals Liposomes Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Spectrum Pharmaceuticals Liposomes Product Portfolio Table 104. Spectrum Pharmaceuticals Recent Development Table 105. Teva Pharmaceutical Company Information Table 106. Teva Pharmaceutical Business Overview Table 107. Teva Pharmaceutical Liposomes Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Teva Pharmaceutical Liposomes Product Portfolio Table 109. Teva Pharmaceutical Recent Development Table 110. Novartis Company Information Table 111. Novartis Business Overview Table 112. Novartis Liposomes Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Novartis Liposomes Product Portfolio Table 114. Novartis Recent Development Table 115. Johnson & Johnson Company Information Table 116. Johnson & Johnson Business Overview Table 117. Johnson & Johnson Liposomes Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Johnson & Johnson Liposomes Product Portfolio Table 119. Johnson & Johnson Recent Development Table 120. Shanghai New Asia Company Information Table 121. Shanghai New Asia Business Overview Table 122. Shanghai New Asia Liposomes Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Shanghai New Asia Liposomes Product Portfolio Table 124. Shanghai New Asia Recent Development Table 125. Sun Pharmaceutical Company Information Table 126. Sun Pharmaceutical Business Overview Table 127. Sun Pharmaceutical Liposomes Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Sun Pharmaceutical Liposomes Product Portfolio Table 129. Sun Pharmaceutical Recent Development Table 130. Key Raw Materials Table 131. Raw Materials Key Suppliers Table 132. Liposomes Distributors List Table 133. Liposomes Customers List Table 134. Research Programs/Design for This Report Table 135. Authors List of This Report Table 136. Secondary Sources Table 137. Primary Sources List of Figures Figure 1. Liposomes Product Image Figure 2. Global Liposomes Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Liposomes Market Size (2021-2032) & (US$ Million) Figure 4. Global Liposomes Sales (2021-2032) & (W Units) Figure 5. Global Liposomes Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Liposomes Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Liposomal Doxorubicin Image Figure 9. Liposomal Amphoteracin B Image Figure 10. Liposomal Paclitaxel Image Figure 11. Others Image Figure 12. Global Liposomes Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 13. Global Liposomes Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Liposomes Sales Market Share by Type (2021-2032) Figure 15. Global Liposomes Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 16. Global Liposomes Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Liposomes Revenue Market Share by Type (2021-2032) Figure 18. Fungal Infection Therapy Image Figure 19. Cancer & Tumor Therapy Image Figure 20. Others Image Figure 21. Global Liposomes Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 22. Global Liposomes Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Liposomes Sales Market Share by Application (2021-2032) Figure 24. Global Liposomes Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 25. Global Liposomes Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Liposomes Revenue Market Share by Application (2021-2032) Figure 27. North America Liposomes Sales and Growth Rate (2021-2032) & (W Units) Figure 28. North America Liposomes Sales Market Share by Country (2021-2032) Figure 29. U.S. Liposomes Sales and Growth Rate (2021-2032) & (W Units) Figure 30. Canada Liposomes Sales and Growth Rate (2021-2032) & (W Units) Figure 31. Mexico Liposomes Sales and Growth Rate (2021-2032) & (W Units) Figure 32. Europe Liposomes Sales and Growth Rate (2021-2032) & (W Units) Figure 33. Europe Liposomes Sales Market Share by Country (2021-2032) Figure 34. Germany Liposomes Sales and Growth Rate (2021-2032) & (W Units) Figure 35. France Liposomes Sales and Growth Rate (2021-2032) & (W Units) Figure 36. U.K. Liposomes Sales and Growth Rate (2021-2032) & (W Units) Figure 37. Italy Liposomes Sales and Growth Rate (2021-2032) & (W Units) Figure 38. Netherlands Liposomes Sales and Growth Rate (2021-2032) & (W Units) Figure 39. Asia Pacific Liposomes Sales and Growth Rate (2021-2032) & (W Units) Figure 40. Asia Pacific Liposomes Sales Market Share by Country (2021-2032) Figure 41. China Liposomes Sales and Growth Rate (2021-2032) & (W Units) Figure 42. Japan Liposomes Sales and Growth Rate (2021-2032) & (W Units) Figure 43. South Korea Liposomes Sales and Growth Rate (2021-2032) & (W Units) Figure 44. Southeast Asia Liposomes Sales and Growth Rate (2021-2032) & (W Units) Figure 45. India Liposomes Sales and Growth Rate (2021-2032) & (W Units) Figure 46. Australia Liposomes Sales and Growth Rate (2021-2032) & (W Units) Figure 47. South America, Middle East and Africa Liposomes Sales and Growth Rate (2021-2032) & (W Units) Figure 48. South America, Middle East and Africa Liposomes Sales Market Share by Country (2021-2032) Figure 49. Brazil Liposomes Sales and Growth Rate (2021-2032) & (W Units) Figure 50. South Africa Liposomes Sales and Growth Rate (2021-2032) & (W Units) Figure 51. Saudi Arabia Liposomes Sales and Growth Rate (2021-2032) & (W Units) Figure 52. Turkey Liposomes Sales and Growth Rate (2021-2032) & (W Units) Figure 53. Argentina Liposomes Sales and Growth Rate (2021-2032) & (W Units) Figure 54. UAE Liposomes Sales and Growth Rate (2021-2032) & (W Units) Figure 55. Egypt Liposomes Sales and Growth Rate (2021-2032) & (W Units) Figure 56. Chile Liposomes Sales and Growth Rate (2021-2032) & (W Units) Figure 57. Global Liposomes Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Liposomes Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Liposomes Revenue (2021-2032) & (US$ Million) Figure 60. North America Liposomes Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Liposomes Revenue (2021-2032) & (US$ Million) Figure 62. Europe Liposomes Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Liposomes Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Liposomes Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Liposomes Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Liposomes Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Liposomes Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Liposomes Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Liposomal Doxorubicin
  • Liposomal Amphoteracin B
  • Liposomal Paclitaxel
  • Others
Applications
  • Fungal Infection Therapy
  • Cancer & Tumor Therapy
  • Others
Companies covered
  • CSPC
  • Fudan-Zhangjiang
  • Gilead Sciences
  • Kingond Pharm
  • Luye Pharma
  • Pacira
  • Sigma-Tau Group
  • Spectrum Pharmaceuticals
  • Teva Pharmaceutical
  • Novartis
  • Johnson & Johnson
  • Shanghai New Asia
  • Sun Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Liposomes Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Liposomes Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Liposomes Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Liposomes Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Liposomes Market Dynamics
  1. 2.1 Liposomes Industry Trends
  2. 2.2 Liposomes Industry Drivers
  3. 2.3 Liposomes Industry Opportunities and Challenges
  4. 2.4 Liposomes Industry Restraints
3 Liposomes Market by Manufacturers
  1. 3.1 Global Liposomes Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Liposomes Sales by Manufacturers (2021-2026)
  3. 3.3 Global Liposomes Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Liposomes Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Liposomes Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Liposomes Manufacturers, Product Type & Application
  7. 3.7 Global Liposomes Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Liposomes Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Liposomes Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Liposomes Tier 1, Tier 2, and Tier 3
4 Liposomes Market by Type
  1. 4.1 Liposomes Type Introduction
  2. 4.1.1 Liposomal Doxorubicin
  3. 4.1.2 Liposomal Amphoteracin B
  4. 4.1.3 Liposomal Paclitaxel
  5. 4.1.4 Others
  6. 4.2 Global Liposomes Sales by Type
  7. 4.2.1 Global Liposomes Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Liposomes Sales by Type (2021-2032)
  9. 4.2.3 Global Liposomes Sales Market Share by Type (2021-2032)
  10. 4.3 Global Liposomes Revenue by Type
  11. 4.3.1 Global Liposomes Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Liposomes Revenue by Type (2021-2032)
  13. 4.3.3 Global Liposomes Revenue Market Share by Type (2021-2032)
5 Liposomes Market by Application
  1. 5.1 Liposomes Application Introduction
  2. 5.1.1 Fungal Infection Therapy
  3. 5.1.2 Cancer & Tumor Therapy
  4. 5.1.3 Others
  5. 5.2 Global Liposomes Sales by Application
  6. 5.2.1 Global Liposomes Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Liposomes Sales by Application (2021-2032)
  8. 5.2.3 Global Liposomes Sales Market Share by Application (2021-2032)
  9. 5.3 Global Liposomes Revenue by Application
  10. 5.3.1 Global Liposomes Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Liposomes Revenue by Application (2021-2032)
  12. 5.3.3 Global Liposomes Revenue Market Share by Application (2021-2032)
6 Global Liposomes Sales by Region
  1. 6.1 Global Liposomes Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Liposomes Sales by Region (2021-2032)
  3. 6.2.1 Global Liposomes Sales by Region (2021-2026)
  4. 6.2.2 Global Liposomes Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Liposomes Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Liposomes Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Liposomes Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Liposomes Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Liposomes Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Liposomes Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Liposomes Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Liposomes Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Liposomes Revenue by Region
  1. 7.1 Global Liposomes Revenue by Region
  2. 7.1.1 Global Liposomes Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Liposomes Revenue by Region (2021-2026)
  4. 7.1.3 Global Liposomes Revenue by Region (2027-2032)
  5. 7.1.4 Global Liposomes Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Liposomes Revenue (2021-2032)
  8. 7.2.2 North America Liposomes Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Liposomes Revenue (2021-2032)
  11. 7.3.2 Europe Liposomes Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Liposomes Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Liposomes Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Liposomes Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Liposomes Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 CSPC
  2. 8.1.1 CSPC Company Information
  3. 8.1.2 CSPC Business Overview
  4. 8.1.3 CSPC Liposomes Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 CSPC Liposomes Product Portfolio
  6. 8.1.5 CSPC Recent Developments
  7. 8.2 Fudan-Zhangjiang
  8. 8.2.1 Fudan-Zhangjiang Company Information
  9. 8.2.2 Fudan-Zhangjiang Business Overview
  10. 8.2.3 Fudan-Zhangjiang Liposomes Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Fudan-Zhangjiang Liposomes Product Portfolio
  12. 8.2.5 Fudan-Zhangjiang Recent Developments
  13. 8.3 Gilead Sciences
  14. 8.3.1 Gilead Sciences Company Information
  15. 8.3.2 Gilead Sciences Business Overview
  16. 8.3.3 Gilead Sciences Liposomes Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Gilead Sciences Liposomes Product Portfolio
  18. 8.3.5 Gilead Sciences Recent Developments
  19. 8.4 Kingond Pharm
  20. 8.4.1 Kingond Pharm Company Information
  21. 8.4.2 Kingond Pharm Business Overview
  22. 8.4.3 Kingond Pharm Liposomes Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Kingond Pharm Liposomes Product Portfolio
  24. 8.4.5 Kingond Pharm Recent Developments
  25. 8.5 Luye Pharma
  26. 8.5.1 Luye Pharma Company Information
  27. 8.5.2 Luye Pharma Business Overview
  28. 8.5.3 Luye Pharma Liposomes Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Luye Pharma Liposomes Product Portfolio
  30. 8.5.5 Luye Pharma Recent Developments
  31. 8.6 Pacira
  32. 8.6.1 Pacira Company Information
  33. 8.6.2 Pacira Business Overview
  34. 8.6.3 Pacira Liposomes Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Pacira Liposomes Product Portfolio
  36. 8.6.5 Pacira Recent Developments
  37. 8.7 Sigma-Tau Group
  38. 8.7.1 Sigma-Tau Group Company Information
  39. 8.7.2 Sigma-Tau Group Business Overview
  40. 8.7.3 Sigma-Tau Group Liposomes Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sigma-Tau Group Liposomes Product Portfolio
  42. 8.7.5 Sigma-Tau Group Recent Developments
  43. 8.8 Spectrum Pharmaceuticals
  44. 8.8.1 Spectrum Pharmaceuticals Company Information
  45. 8.8.2 Spectrum Pharmaceuticals Business Overview
  46. 8.8.3 Spectrum Pharmaceuticals Liposomes Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Spectrum Pharmaceuticals Liposomes Product Portfolio
  48. 8.8.5 Spectrum Pharmaceuticals Recent Developments
  49. 8.9 Teva Pharmaceutical
  50. 8.9.1 Teva Pharmaceutical Company Information
  51. 8.9.2 Teva Pharmaceutical Business Overview
  52. 8.9.3 Teva Pharmaceutical Liposomes Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Teva Pharmaceutical Liposomes Product Portfolio
  54. 8.9.5 Teva Pharmaceutical Recent Developments
  55. 8.10 Novartis
  56. 8.10.1 Novartis Company Information
  57. 8.10.2 Novartis Business Overview
  58. 8.10.3 Novartis Liposomes Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Novartis Liposomes Product Portfolio
  60. 8.10.5 Novartis Recent Developments
  61. 8.11 Johnson & Johnson
  62. 8.11.1 Johnson & Johnson Company Information
  63. 8.11.2 Johnson & Johnson Business Overview
  64. 8.11.3 Johnson & Johnson Liposomes Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Johnson & Johnson Liposomes Product Portfolio
  66. 8.11.5 Johnson & Johnson Recent Developments
  67. 8.12 Shanghai New Asia
  68. 8.12.1 Shanghai New Asia Company Information
  69. 8.12.2 Shanghai New Asia Business Overview
  70. 8.12.3 Shanghai New Asia Liposomes Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Shanghai New Asia Liposomes Product Portfolio
  72. 8.12.5 Shanghai New Asia Recent Developments
  73. 8.13 Sun Pharmaceutical
  74. 8.13.1 Sun Pharmaceutical Company Information
  75. 8.13.2 Sun Pharmaceutical Business Overview
  76. 8.13.3 Sun Pharmaceutical Liposomes Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Sun Pharmaceutical Liposomes Product Portfolio
  78. 8.13.5 Sun Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Liposomes Value Chain Analysis
  2. 9.1.1 Liposomes Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Liposomes Production Mode & Process
  6. 9.2 Liposomes Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Liposomes Distributors
  9. 9.2.3 Liposomes Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst